Fieldfisher partner joins Pinsent Masons in London

Nicole Jadeja joins Pinsent Masons from her previous role as co-head of the life sciences department at Fieldfisher in London. She will work alongside Pinsent Masons’ head of IP and life sciences, Clare Tunstall, to strengthen Pinsent Masons’ life sciences offering. There are now eleven IP partners working from London, and 28 life sciences partners across its UK offices.

Prior to her three and a half years as a partner at Fieldfisher, Jadeja was a partner at international IP litigation boutique Rouse. She joined Rouse in 2008 from Nabarro. It is thought a number of Jadeja’s current clients at Fieldfisher will continue working with her.

Nicole Jadeja

Pinsent Masons knew Jadeja by reputation and followed her work on a number of high-profile patent actions. A combination of its knowledge of sector specialists combined with output from recruitment consultant research led to the hire.

Supreme Court connection

Previously, Jadeja worked alongside Pinsent Masons solicitors Charlotte Weekes and Tamsin Cornwell during the Eli Lilly/ICOS vs. Actavis Group, Actavis UK, Teva UK, Teva Pharmaceuticals and Mylan case. The case was heard by the UK Supreme Court earlier in 2019. Pinsent Masons acted for Teva Pharmaceuticals. Nicole Jadeja intervened for the UK Bioindustry Association, where she is vice chair of the IP committee.

Pinsent Masons also recently recruited Jules Fabre as legal director for intellectual property in its Paris office. Fabre had also worked alongside Pinsent Masons in the Supreme Court case. This was in his previous role as senior counsel at Teva Pharmaceuticals.

Doubling efforts

However, the appointments of Jadeja and Fabre are not the only recent changes at the firm. In July, the firm also announced the appointment of Michael Finn as a partner in its Dublin office. Finn, also a specialist in life sciences litigation, joined Pinsent Masons from Irish full-service IP firm Matheson. There are now nine partners in its Dublin office.

Pinsent Masons hopes to double the size of its life sciences practice over the coming two to three years. Tunstall says, “Our ambition is to recruit an additional 20-plus partner-level hires into our European sector team across a range of skillsets relevant to clients in this sector.”